Table 5.
Differences in the Percentage of Sites in the Dominant Lower and Upper Extremities That Did Not Feel Cold Between Cancer Survivors With (n=426) and Without (n=197) Chemotherapy Induced Neuropathy (CIN)
| Site | No CIN 31.6% (n=197) |
CIN 68.4% (n=426) |
p-value* |
|---|---|---|---|
| % (n) | % (n) | ||
| Lower Extremity Sites | |||
| Top of great toe at 1st MP joint | 47.7 (93) | 62.6 (265) | .001 |
| Pad of great toe | 64.6 (126) | 80.9 (342) | <.001 |
| Dorsum of foot midpoint | 24.6 (48) | 36.4 (154) | .004 |
| Medial malleolus | 33.8 (66) | 45.6 (193) | .007 |
| Upper Extremity Sites | |||
| Pad of index finger | 15.9 (31) | 29.6 (125) | <.001 |
| Pad of little finger | 28.7 (56) | 37.4 (158) | .037 |
| Dorsal metacarpal area of the hand | 7.7 (15) | 9.7 (41) | .455 |
| Wrist | 3.1 (6) | 5.7 (24) | .226 |
*
Fisher’s Exact test
Abbreviations: MP = metocarpophalangeal